BlossomHill Therapeutics rallies $71m Series A
BlossomHill Therapeutics Inc, a biopharmaceutical company focusing on oncology and autoimmune disorders, has raised $71 million in Series A financing.
BlossomHill Therapeutics Inc, a biopharmaceutical company focusing on oncology and autoimmune disorders, has raised $71 million in Series A financing.
Copyright PEI Media
Not for publication, email or dissemination
